Calegari, Maria Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 1.675
AS - Asia 918
EU - Europa 820
SA - Sud America 203
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 3.667
Nazione #
US - Stati Uniti d'America 1.626
SG - Singapore 423
DE - Germania 194
VN - Vietnam 161
BR - Brasile 157
CN - Cina 149
IT - Italia 141
PL - Polonia 106
SE - Svezia 96
FR - Francia 76
FI - Finlandia 50
GB - Regno Unito 44
IN - India 33
IE - Irlanda 32
ID - Indonesia 29
JP - Giappone 29
AR - Argentina 26
CA - Canada 19
HK - Hong Kong 18
MX - Messico 18
ZA - Sudafrica 17
BD - Bangladesh 16
UA - Ucraina 15
RU - Federazione Russa 14
TR - Turchia 13
ES - Italia 10
CI - Costa d'Avorio 8
EC - Ecuador 8
MA - Marocco 7
NL - Olanda 7
AT - Austria 6
IQ - Iraq 6
CZ - Repubblica Ceca 5
PK - Pakistan 5
SA - Arabia Saudita 5
IR - Iran 4
LT - Lituania 4
PH - Filippine 4
PY - Paraguay 4
BE - Belgio 3
CH - Svizzera 3
IL - Israele 3
JM - Giamaica 3
KR - Corea 3
LB - Libano 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
TN - Tunisia 3
VE - Venezuela 3
AU - Australia 2
BY - Bielorussia 2
CO - Colombia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
EU - Europa 2
GE - Georgia 2
KE - Kenya 2
NG - Nigeria 2
PT - Portogallo 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
DM - Dominica 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
LK - Sri Lanka 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.667
Città #
Ashburn 581
Singapore 254
Chandler 146
San Jose 108
Warsaw 98
Hanoi 50
Rome 47
Ho Chi Minh City 45
Los Angeles 44
Beijing 40
Munich 39
Dublin 32
New York 31
Helsinki 30
Fairfield 27
Houston 27
Wilmington 26
Chicago 24
Lauterbourg 24
Council Bluffs 23
Tokyo 22
Milan 20
Jakarta 19
Boston 17
Hyderabad 17
Ann Arbor 16
Dearborn 16
Frankfurt am Main 16
Hong Kong 16
San Mateo 16
Woodbridge 16
Hefei 15
São Paulo 15
The Dalles 15
Seattle 14
Cambridge 13
Cattolica 13
Orem 13
Santa Clara 13
Johannesburg 11
Paris 11
Princeton 11
Marseille 10
Jacksonville 9
Poplar 9
Redwood City 9
Turku 9
Abidjan 8
Dallas 8
Moscow 8
Nanjing 8
Brooklyn 7
Buenos Aires 7
Da Nang 7
Hải Dương 7
Lappeenranta 7
Mexico City 7
Izmir 6
Montreal 6
Atlanta 5
Bari 5
Buffalo 5
Chennai 5
Guangzhou 5
Kent 5
London 5
Manchester 5
Mountain View 5
Nürnberg 5
Querétaro 5
St Louis 5
Washington 5
Amsterdam 4
Bexley 4
Brasília 4
Denver 4
Lawrence 4
Phoenix 4
Roubaix 4
Salt Lake City 4
San Francisco 4
Shanghai 4
Shenyang 4
Thái Bình 4
Toronto 4
Andover 3
Augusta 3
Belo Horizonte 3
Berlin 3
Boardman 3
Bremen 3
Curitiba 3
Dakar 3
Elk Grove Village 3
Hangzhou 3
Islamabad 3
Leawood 3
Manassas 3
Newark 3
Piacenza 3
Totale 2.325
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 614
Diagnosis and management of breast lymphoma: A single-institution retrospective analysis 267
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 234
Mastectomy in precision oncology era: Myth or reality? 191
Trastuzumab-induced corneal ulceration: successful no-drug treatment of a "blind" side effect in a case report 182
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 151
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 145
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 140
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 130
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial 130
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC) 129
Clinical and Molecular Features in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Colorectal Cancer 120
Paradox CA 15-3 increase in metastatic breast cancer patients treated with everolimus: A change of paradigm in a case series 119
Diffuse liver infiltration by lobular breast carcinoma: Shear wave elastography as gold standard imaging study. 114
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 113
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis 100
LUX-Lung 7: is there enough data for a final conclusion? 100
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study 99
Combination of endoscopic ultrasound-guided radiofrequency ablation and adaptive radiation therapy for the treatment of lymph node metastases from colon adenocarcinoma: A case report 98
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 97
PTEN in colorectal cancer: Shedding light on its role as predictor and target 93
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 86
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse 82
Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC 76
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance 56
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study 54
Totale 3.720
Categoria #
all - tutte 12.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.211


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 10 7
2021/2022156 12 6 5 13 2 4 5 19 5 15 36 34
2022/2023365 47 52 19 57 15 38 20 38 33 10 15 21
2023/2024642 7 46 9 6 10 38 232 252 2 8 16 16
2024/2025442 5 11 36 14 30 14 14 8 45 52 108 105
2025/20261.628 191 79 114 288 307 72 237 95 127 95 23 0
Totale 3.720